Commentary: A multicenter, real-world cohort study: effectiveness and safety of Azvudine in hospitalized COVID-19 patients with pre-existing diabetes.

Front Endocrinol (Lausanne) · 2026 · PMC12864116 · PMID 41640745

Europe PMC DOI

hedged sentence

0.0440

closest p · 0.9× alpha

0.0440

boldest claim

The sentences

nominally significantp=0.044actually significant

The authors state that no significant interactions were observed, yet a nominally significant interaction (p=0.044) is reported for HbA1c in the composite outcome ( 1 ).

also in 4,767 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.